Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

BACKGROUND: Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend routine prophylactic coverage with granulocyte colony-stimulating factor (G-CSF)—such as pegfilgrastim—for most patients receiving chemotherapy with an intermediate...

Descripción completa

Detalles Bibliográficos
Autores principales: Weycker, Derek, Doroff, Robin, Hanau, Ahuva, Bowers, Charles, Belani, Rajesh, Chandler, David, Lonshteyn, Alexander, Bensink, Mark, Lyman, Gary H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688232/
https://www.ncbi.nlm.nih.gov/pubmed/31399079
http://dx.doi.org/10.1186/s12885-019-6010-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688232/
https://www.ncbi.nlm.nih.gov/pubmed/31399079
http://dx.doi.org/10.1186/s12885-019-6010-9

Ejemplares similares